ExuFlex01 Post Market Clinical Follow-up Investigation

• Research type

  Research Study

• Full title

  Prospective, open, non-comparative, multi-centre, post market clinical follow-up (PMCF) investigation to follow the progress of exuding chronic wounds to healing using Exufiber® as primary dressing, and Mepilex® Border Flex (Mepilex Border Comfort).

• IRAS ID

  294116

• Contact name

  Paul Chadwick

• Contact email

  paul.chadwick@cop.org.uk

• Clinicaltrials.gov Identifier

  NCT04960553

• Duration of Study in the UK

  0 years, 9 months, 12 days

• Research summary

  The overall objective of this post market clinical follow-up (PMCF) investigation is to follow the progress of exuding chronic wounds to healing, or up to 12 weeks, whichever occurs first, consecutively using Exufiber® as primary dressing, and Mepilex® Border Flex (Mepilex Border Comfort) as primary dressing.

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  21/LO/0113

• Date of REC Opinion

  12 Mar 2021

• REC opinion

  Further Information Favourable Opinion